Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. (SES: 1J5) is trading at S$0.35, about ₹26 at today's SGD/INR rate, as of 11 Nov 2026, 1:43 AM ET. Indian residents can buy Hyphens Pharma International from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
S$0.35
Today's high
S$0.35
52 week low
S$0.30
52 week high
S$0.39
1J5 opened at S$0.35, closed previously at S$0.35, and has traded between S$0.30 and S$0.39 over the past 52 weeks.
About
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products, including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries. This segment focuses on various therapeutic areas, such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. Its Proprietary Brands segment develops, markets, and sells dermatological products comprising Ceradan, TDF, and CG210; health supplements under the Ocean Health brand covering areas, such as heart, joint, physical, cognitive, eye, and health; and pharmaceuticals. The Digital Platform and E-Pharmacy segment operates a digital platform that services procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies primarily in Singapore. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
Key statistics
Avg. volume
86.30K
Market cap
S$108.11M
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.18
Dividend yield
—
Last dividend
S$0.02
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Hyphens Pharma International from India
Indian residents can buy Hyphens Pharma International shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Hyphens Pharma International from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to SGD.
Search for Hyphens Pharma International and place an order
Find Hyphens Pharma International by name or by its ticker, 1J5, and choose an order type. Hyphens Pharma International trades 6:30 am – 2:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Hyphens Pharma International position in SGD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Trading and taxes when buying Hyphens Pharma International from India
Trading and limits
- Trading hours
- 9:00 am – 5:00 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Singapore levies 0% withholding tax on dividends from resident companies.Dividend tax explained
- Transaction tax
- Singapore levies no stamp duty or transaction tax on listed equities.
- Estate or inheritance tax
- May applySingapore imposes no estate or inheritance tax on listed securities.Estate tax explained
FAQs
Can Indian residents buy Hyphens Pharma International stock?
Yes. Hyphens Pharma International (1J5) has been listed on the Singapore Exchange since 2018, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to SGD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Hyphens Pharma International share cost in rupees?
One Hyphens Pharma International share is S$0.35 — about ₹26 at an SGD/INR rate of 73.41 on 10 Nov 2026. Both the Hyphens Pharma International price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Hyphens Pharma International from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Hyphens Pharma International shares taxed in India?
Singapore does not levy capital gains tax on the sale of shares, ETFs or REITs, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the SGD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hyphens Pharma International price. Paasa issues a capital-gains statement for your return.
Does Hyphens Pharma International pay a dividend, and how is it taxed in India?
Yes. Hyphens Pharma International pays a dividend — the most recent was S$0.02 per share, about ₹1.10. Dividends are taxed at your slab rate in India. Singapore levies 0% withholding tax on dividends from resident companies. Paasa's dividend report covers each payment.
When can I trade Hyphens Pharma International from India?
The Singapore Exchange trades 6:30 am – 2:30 pm IST in Indian time. Orders can only execute during that window.
Is there estate or inheritance tax on Hyphens Pharma International shares held from India?
Singapore imposes no estate or inheritance tax on listed securities.
Are there transaction taxes when buying Hyphens Pharma International?
Singapore levies no stamp duty or transaction tax on listed equities.
Do I have to declare Hyphens Pharma International shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Hyphens Pharma International holding, its cost and its closing value.
How do I sell Hyphens Pharma International and bring the money back to India?
You sell during market hours (6:30 am – 2:30 pm IST) and the proceeds settle in SGD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.